Literature DB >> 16604582

Prostate stem cell antigen (PSCA) expression in human prostate cancer tissues: implications for prostate carcinogenesis and progression of prostate cancer.

Zhao Zhigang, Shen Wenlv.   

Abstract

Entities:  

Mesh:

Year:  2006        PMID: 16604582     DOI: 10.1093/jjco/hyi253

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


× No keyword cloud information.
  5 in total

1.  Androgen ablation augments prostate cancer vaccine immunogenicity only when applied after immunization.

Authors:  Yi T Koh; Andrew Gray; Sean A Higgins; Bolyn Hubby; W Martin Kast
Journal:  Prostate       Date:  2009-05-01       Impact factor: 4.104

2.  Detection of prostate stem cell antigen expression in human prostate cancer using quantum-dot-based technology.

Authors:  Yuan Ruan; Weimin Yu; Fan Cheng; Xiaobin Zhang; Stéphane Larré
Journal:  Sensors (Basel)       Date:  2012-04-27       Impact factor: 3.576

3.  Prostate Stem Cell Antigen Expression in Radical Prostatectomy Specimens Predicts Early Biochemical Recurrence in Patients with High Risk Prostate Cancer Receiving Neoadjuvant Hormonal Therapy.

Authors:  Sung Han Kim; Weon Seo Park; Sun Ho Kim; Boram Park; Jungnam Joo; Geon Kook Lee; Jae Young Joung; Ho Kyung Seo; Jinsoo Chung; Kang Hyun Lee
Journal:  PLoS One       Date:  2016-03-16       Impact factor: 3.240

4.  Knockdown of PSCA induces EMT and decreases metastatic potentials of the human prostate cancer DU145 cells.

Authors:  Ran Kang; Shankun Zhao; Luhao Liu; Futian Li; Ermao Li; Lianmin Luo; Lihua Xu; ShawPong Wan; Zhigang Zhao
Journal:  Cancer Cell Int       Date:  2016-03-15       Impact factor: 5.722

5.  The Correlation between PSCA Expression and Neuroendocrine Differentiation in Prostate Cancer.

Authors:  Qian Xiang; Zhiguo Zhu; Lianmin Luo; Jiamin Wang; Yangzhou Liu; Yihan Deng; Mingda Zhou; Zhigang Zhao
Journal:  Biomed Res Int       Date:  2020-09-24       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.